Directorate change - Chief Financial Officer
HealthBeacon plc ("HealthBeacon" or "the Company"), a leader in devices and software to manage critical and chronic medications, today announces that, Laurence Flavin, Chief Financial Officer, has informed the Board of his intention to leave the Company. Laurence will step down as Executive Director, Chief Financial Officer and Company Secretary of HealthBeacon within the next six months.
A process to appoint a successor is now underway in line with Board succession planning and Laurence will work with the Chief Executive and the Board to ensure an orderly transition.
Jim Joyce, Co-Founder and Chief Executive of HealthBeacon, commented: "Laurence has been a committed and professional colleague and I am very grateful to him for the significant contribution he has made to the business during his tenure. Laurence was instrumental in our successful IPO process last year and has built an excellent finance team that continues to serve the Company very well. I wish Laurence every success and look forward to continuing to work him during this transition period."
Robert Garber, Chairman of HealthBeacon, said: "I would like to thank Laurence for his dedication to HealthBeacon during his time with the Company and wish him success in the future. The Board has now moved to commence a search process to identify and appoint a successor to lead the strong finance team at HealthBeacon as the Company pursues its next phase of growth."
Laurence Flavin said: "I'd like to thank Jim, the Board and all my colleagues at HealthBeacon for the rewarding and fulfilling time I spent with the Company, and I wish them continued success in the future."
| Enquiries: |
|
| HealthBeacon: Jim Joyce
|
|
| Goodbody (Euronext Listing Sponsor and Broker): David Kearney |
+353 (1) 667 0420 |
| Stephen Kane |
|
|
Drury (Public Relations): |
|
| Cathal Barry |
+353 (0) 87 227 9281 |
| Paul Clifford |
+353 (0) 87 327 2161 |
About HealthBeacon
Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company that develops smart tools for managing medications for patients in the home. The HealthBeacon Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence (AI) driven data analytics. Peer reviewed evidence supports a 19% improvement in therapy persistence by patients and up to 26% improvement in adherence to therapy, which improves clinical outcomes and significantly improves efficiency in health systems. The Company has expanded its offering to growth management with the launch of its integrated Smart Scale and oral adherence with the launch of HB Wave which integrates with its existing technology. The Company operates across Europe, North America and the United Kingdom and employs more than 70 people and has obtained more than 30 design and utility patents. The Company's mission is to become the world's leading digital therapeutics platform for patients managing medications in the home.
Ends
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.